VIP and cancer: Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinalpeptide (VIP) through the binding of vasoactive intestinal peptide receptors (VIPRs),perform a wide variety of effects in human cancers, including glioblastoma multiforme(GBM).